UBS Group’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-27,320
Closed -$408K 7809
2015
Q4
$408K Sell
27,320
-1,680
-6% -$25.6K ﹤0.01% 4120
2015
Q3
$390K Hold
29,000
﹤0.01% 4108
2015
Q2
$354K Sell
29,000
-1,140
-4% -$15.2K ﹤0.01% 4393
2015
Q1
$338K Sell
30,140
-110,340
-79% -$1.54M ﹤0.01% 4444
2014
Q4
$1.76M Buy
+140,480
New +$1.14M ﹤0.01% 3021

Other funds holding FRO

UBS Group's FRO Position: Q2 2026 in Review

UBS Group reduced its Frontline (FRO) stake by 4.9% in Q2 2026, selling an estimated $4.48M and leaving 2,390,273 shares worth $83.2M. The position accounts for 0.01% of the portfolio, ranked #1263.

UBS Group first reported a position in FRO in Q4 2014 and has held it in 47 quarters since. The position peaked at $87.6M in Q1 2026. 261 funds tracked by Wall St. Rank hold FRO as of Q2 2026.

  • UBS Group held 2,390,273 shares of Frontline worth $83.2M as of Q2 2026.
  • UBS Group sold 122,012 Frontline shares in Q2 2026, an estimated $4.48M.
  • Frontline made up 0.01% of UBS Group's portfolio in Q2 2026, its #1263 holding.
  • UBS Group first reported a position in Frontline in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Frontline position peaked at $87.6M in Q1 2026.
  • 261 funds tracked by Wall St. Rank held Frontline as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.